Parabon’s Dr. Ellen Greytak to Speak on Forensic DNA Phenotyping at ISHI 2015

Greytak invited to discuss the company’s revolutionary Snapshot™ DNA Phenotyping Service for predicting ancestry and physical appearance from DNA

Dr. Ellen McRae Greytak, Director of Bioinformatics,  Parabon NanoLabs
Dr. Ellen McRae Greytak, Director of Bioinformatics, Parabon NanoLabs

Visit Parabon NanoLabs at ISHI Booth 321

Parabon Nanolabs Logo
Parabon Nanolabs

Reston, Va. ( – Parabon NanoLabs’ (Parabon), Director of Bioinformatics, Dr. Ellen McRae Greytak, will deliver a talk entitled DNA Phenotyping: Predicting Ancestry and Physical Appearance from Forensic DNA on 15 October at 9 a.m. at the International Symposium on Human Identification (ISHI).  Parabon will also be exhibiting in booth 321 at the symposium, which will be held 12-15 October 2015 at the Gaylord Texan Resort and Convention Center in Grapevine, Texas.

Dr. Greytak serves as the scientific lead for Parabon’s Snapshot™ Forensic DNA Phenotyping Service.  Parabon unveiled Snapshot last December, after four years of development with funding support from the US Department of Defense.  She will discuss the Snapshot research program and how the service is being actively used by law enforcement.

The ISHI conference attracts attendees from around the world in fields such as medicine, forensics, anthropology, and law enforcement.  Now in its 26th year, ISHI has witnessed new technologies, changing policies, and new trends in forensics. Over 100 scientific poster presentations will occur over the 3-day event, and more than 50 vendors in the fields of forensics, DNA analysis, evidence collection, and DNA phenotyping will attend.  On being invited to present at the conference, Greytak said, “ISHI is one of the premier forensic conferences in the US and an outstanding venue through which to promote new technologies like Snapshot.  We are most pleased to have the opportunity to present and exhibit at this year’s event.”

About Parabon NanoLabs, Inc.:
Parabon NanoLabs is a vertically integrated DNA technology company that develops next-generation forensic and therapeutic products, which leverage the enormous power of DNA.  Staffed by a uniquely qualified team of scientists and technologists, with expertise ranging from bioinformatics and chemistry to computer science and pharmacology, Parabon is bringing to market revolutionary new products and services made possible by recent advances in DNA sequencing, analysis and manufacturing technologies.